According to a recent CNN article, Pfizer and BioNTech have submitted applications asking the FDA to grant emergency use authorization to their updated COVID-19 vaccine. The formulation has been updated to combine the original vaccine with one tailored to kill Omicron variants BA.4 and BA.5. It is administered as a single 30 microgram dose intended for people age 12 and older.
